Medinice FCF/Debt

What does Medinice do? Medinice SA is a healthcare company based in Warsaw, Poland, operating within the Health Care sector. The company went public on September 25, 2018, with its ticker listed as ICE.WA and ISIN PLMDNCE00016. Medinice SA specializes in providing cardiological and cardiosurgical devices and solutions, focusing on the development and commercialization of safe, minimally invasive medical technologies. Its portfolio includes projects such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, and Pacepress, all of which are designed with global market potential in mind. The company collaborates with research centers across Poland and Europe to advance its medical device innovations. Medinice SA emphasizes the commercialization of inventions developed by its co-founders and through acquired projects, aiming to license these technologies worldwide for the production of medical devices. The company's headquarters are located in Warsaw, within the Mazowieckie region. Its website, www.medinice.pl, serves as a primary source of information for stakeholders and potential partners. Medinice SA is committed to delivering innovative solutions that address critical needs in cardiology and cardio surgery, leveraging partnerships and research collaborations to drive growth and expand its global footprint. The firm's strategic focus on minimally invasive solutions aligns with current trends in medical technology aimed at improving patient outcomes and reducing procedural risks. Medinice is one of the most popular companies on Eulerpool.